🧬 iPSC-Derived Cell Therapies Symposium

Advancing the Future of Regenerative Medicine 

We are entering an extraordinary era for regenerative medicine — one where iPSC-derived cell therapies hold the potential to transform the treatment of some of the world’s most challenging diseases. 

This symposium will bring together a dynamic international community of scientists, clinicians, biotech leaders, manufacturers, regulators, and innovators dedicated to accelerating the development of transformative therapies for patients. 

The development of induced pluripotent stem cell (iPSC)-derived therapies is opening exciting new opportunities to create innovative — and potentially curative — treatments for diseases with limited or no therapeutic options. 

As some of the most advanced therapies in modern medicine, these disruptive technologies also bring significant scientific, regulatory, manufacturing, and clinical challenges linked to the complexity of biological products. 

This symposium adopts a unique patient-centered approach, starting with the desired clinical outcome and working backward to optimize every stage of development. 

From “Bedside Back to Bench”

Unlike traditional scientific meetings based on the classic “bench-to-bedside” pathway, this program takes a reverse-development perspective. 

We begin with the ultimate goal:

• Safe therapies
• Effective clinical outcomes
• Successful and scalable cell therapy products

Using this framework, the symposium explores how discovery, translational science, manufacturing, regulatory strategy, and clinical development can be aligned to accelerate patient access to next-generation therapies. 

Why Attend?

• Discover the latest advances in iPSC-derived therapies
• Network with leading international experts and innovators
• Gain strategic insights into translational and clinical development
• Explore manufacturing, scalability, and regulatory challenges
• Connect with key stakeholders across academia and industry